Prospective registry study of airpotato yam (Huang Yaozi) in the treatment of hyperthyroidism

Internal medicine of traditional Chinese medicine (endocrine)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2200005861

Enrollment

Unknown

Registered

2022-04-14

Start date

2022-04-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperthyroidism

Interventions

Huangyaozi group:TCM prescription containing huangyaozi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The age is 18 to 70 years old (including boundary value), and there is no limit on gender; 2) Meet the diagnostic criteria of hyperthyroidism in modern medicine; 3) It is planned to start taking traditional Chinese medicine prescriptions containing huangyaozi to treat the disease; 4) Informed consent has been signed.

Exclusion criteria

Exclusion criteria: 1) Patients who have received iodine-131 or surgical treatment; 2) Patients with severe other diseases or mental disorders; 3) Pregnant and lactating women and those are planing for pregnancy in the near future.

Design outcomes

Primary

Measure	Time frame
Serum thyrotropin;	—

Secondary

Measure	Time frame
Triiodothyronine;thyroid peroxidase antibody (TPOAb);Free thyroxine;Thyroid color Doppler ultrasound;TCM syndrome score;thyroglobulin antibody (TGAb);Thyrotropin receptor antibody;Free triiodothyronine;Twelve lead ECG;Hyperthyroidism related symptoms and signs;Thyroxine;	—

Countries

China

Contacts

Public ContactLinhua Zhao

melonzhao@163.com010-88001166

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026